A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

ABSTRACT: Intervention name : OCV-C02 INN of the intervention : - Dosage And administration of the intervention : Once-weekly subcutaneous injection (0.3, 1 3 and 6 mg/body) Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Primary outcome(s): safety Dose Limiting Toxicity (DLT) Common Terminology Criteria for Adverse Events (CTCAE), ver. 4.0 Study Design: multicenter, open, non-comparative study

DISEASE(S): Advanced Or Relapsed Colorectal Cancer

PROVIDER: 2657927 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR